StockTipsArenaBeta

BUY Aurobindo Pharma — Rajesh Bhosale, Angel One

BUYAurobindo Pharma
Aurobindo Pharma share price target & all analyst calls

byRajesh Bhosale, Angel OneHorizon: NA (inferred Swing (≤2wk))29 Sept 2026via ET Now (Live)

Entry₹1,704.2Inferred
Target₹1,760
Total upside +3.27% (call closed)
Stop loss₹1,670-2.01% risk
Exit₹1,67030 Sept 2026, 10:00 am
Stop-loss hit-2.01%
Follow Rajesh Bhosale for new calls(32% target hit, 25 closed calls)Get alertsWatch AUROPHARMA for new buy/sell callsGet alertsSee 282 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 30 Sept 2026
10 supporting1 opposing
Supports the BUY call (10)

1 advisor has an active short-term BUY call on this stock, issued in the last 14 days

Advisor consensus · adjacent horizon·24 Sept · 5d ago

Multiple growth triggers ahead for Aurobindo Pharma as outlook stays strong

NewsGoogle News·22 Sept · 1w ago

(opens in new tab)

1 other SEBI-registered advisor has an active swing BUY call on this stock, issued in the last 14 days

Advisor consensus · same horizon·21 Sept · 1w ago

Aurobindo Pharma stock edges higher as US tariff risks and FDA approvals shape outlook

NewsGoogle News·19 Sept · 1w ago

(opens in new tab)

Aurobindo Pharma Share Price rises: stock analysis note

NewsGoogle News·17 Sept · 2w ago

(opens in new tab)
Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (1)

1 advisor has an active short-term SELL call on this stock

Advisor consensus · adjacent horizon·6 Aug · 2mo ago

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Aurobindo Pharma

All analyst calls on Aurobindo Pharma

More from Rajesh Bhosale, Angel One

Every call and its outcome